June 16, 2014 — Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
June 5, 2014 — Mercator MedSystems is in the midst of its prospective, 300-patient, 30-site DANCE (Dexamethasone to the ...
June 05, 2014
May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston ...
May 16, 2014
May 7, 2014 — Women face greater limits on their lifestyle and have more severe symptoms as a result of peripheral ...
May 07, 2014April 23, 2014 — Interim results from The Chocolate Bar Registry conducted in the United States demonstrate that use of ...
April 23, 2014April 7, 2014 — GE Healthcare showcased a new suite of connected cardiovascular technologies, including several for ...
April 08, 2014
April 1, 2014 — The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat ...
April 01, 2014
March 11, 2014 — The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 ...
March 11, 2014
February 28, 2014 — Cordis Corp. announced an agreement with TriReme Medical Inc. that grants the company exclusive ...
February 28, 2014February 28, 2014 — Mercator MedSystems released pilot study data from a single-arm, open label study of 20 patients ...
February 28, 2014
February 18, 2014 — Medtronic Inc. launched in Europe its Total across crossing catheter. Total received CE marking for ...
February 18, 2014
February 6, 2014 — Boston Scientific launched in the United States the OffRoad Re-Entry Catheter System to treat ...
February 06, 2014
January 28, 2014 — AtheroMed, a developer of catheter technologies for treating peripheral artery disease (PAD) ...
January 28, 2014
Bard’s Drug Coated Balloon, Below the Knee Clinical Trial Discussed at Leipzig Interventional Course
January 30, 2014 — Experts presented six-month LEVANT 2 trial results for C. R. Bard Inc.’s Lutonix drug coated balloon ...
January 28, 2014
January 23, 2014 – Six-month results of the ESPRIT trial suggest a bioresorbable drug-eluting scaffold is effective in ...
January 23, 2014